Knockdown of MCM6 was related to a delay in S/G2-phase progression with downregulation of CDK2, CDK4, CyclinA, CyclinB1, CyclinD1, and CyclinE in HCC [86]. This evidence concerns the gene MCM6 and hepatocellular carcinoma.